Rosmanol Effectively Prevents Diethylnitrosamine-induced Hepatocellular Carcinoma in Rats by Regulating the PI3K/Akt Signaling Pathway
Wei Cao1, Qi Liu2, Ying Wang3, Lianfeng Chen4★★ Corresponding author
- 1Department of Oncology, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, Hubei, CHINA.
- 2Department of Hepatobiliary Pancreatic and Splenic Surgery, Huaian Hospital of Huaian City, Huaian, Jiangsu, CHINA.
- 3Department of Hyperbaric Oxygen, General Hospital of Western Theater of Chinese People’s Liberation Army, Chengdu, Sichuan, CHINA.
- 4Department of General Surgery, Qian County People’s Hospital, Qianxian, Shaanxi, CHINA.
CORRESPONDENCE
Lianfeng Chen
Department of General Surgery, Qian County People’s Hospital, Qianxian, Shaanxi, CHINA.
Received: 13-05-2024; Accepted: 07-10-2024.
Volume 21, Issue 3 · pp. 1022–1033 · PUBLISHED 2025 · DOI: 10.1177/09731296241298349
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: Hepatocellular carcinoma (HCC) is the third principal reason for tumor-linked fatalities globally. There is no effective cure for HCC due to rapid progression and poor prognosis. Rosmanol (RM) is a phenolic diterpene antioxidant that exhibits anti-inflammatory and anticancer properties. Objectives: This research aims to examine the chemopreventive efficacy of RM on the PI3K/Akt pathway as a potential mechanism for its protective effect against N-diethylnitrosamine (DEN)-induced HCC. Materials and Methods: Wistar albino male rats were separated into four sets: normal control (NC); DEN-induced HCC model; DEN+RM (40 mg/kg bw); and RM (40 mg/kg bw) alone. To evaluate the chemopreventive mechanism, we assessed the change in body weight, liver weight, hepatotoxicity markers, antioxidant enzymes, lipid peroxidation, proliferation proteins, cytokines, histopathology, and western blot. Results and Conclusion: Our data revealed that RM could reduce the loss of body weight, liver weight, toxicity enzymes, oxidative stress, inflammation, and restructuring of the hepatocellular architecture against DEN-stimulated HCC rats. RM-alone treated rats exhibited comparable activity with NC. Furthermore, RM attenuates PCNA and cyclin-D1 protein expression by the regulation of the PI3K/Akt pathway. The possible chemopreventive activities of RM may be owing to its antioxidative, anti-inflammatory, and antiproliferative effects. Thus, RM may aid as an innovative remedial agent for HCC treatment.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Cao, W., Liu, Q., Wang, Y., & Chen, L. (2025). Rosmanol Effectively Prevents Diethylnitrosamine-induced Hepatocellular Carcinoma in Rats by Regulating the PI3K/Akt Signaling Pathway. Pharmacognosy Magazine, 21(3), 1022–1033. https://doi.org/10.1177/09731296241298349
